| Auteur | |
|---|---|
| jiraporn66 | 21 Jan 2022 - 06:16:00 |
| 470 Posts |
 UNICEF official said onlySLOTalready making money as original capital. Especially if you have a winning formula. It is also used in the game. We guarantee that the prize money will not be delivered. december More than 100 million doses of the coronavirus vaccine have been rejected by the public. On January 14, 2022, the Al Jazeera news agency reported that UNICEF officials said last December Poor countries have had to throw away more than 100 million doses of the COVID-19 vaccine distributed through the COVAX program, mainly because the vaccine is nearing its expiration date. The figure shows barriers to vaccination for people around the world. Despite the increasing number of vaccines, COVAX has delivered nearly a billion doses of vaccines in nearly 150 countries. Eteva Gadilly, United Nations director of procurement, UNICEF. revealed at the European Parliament that December only one month More than 100 million people have refused vaccinations, the main reason being the delivery of vaccines with a short shelf life left.” Many poor countries have also faced delays in vaccine procurement. due to insufficient storage facility This includes the lack of a freezer for storing vaccines. However, UNICEF did not specify exactly how many vaccines were discarded. In addition to the vaccine that has been discarded There are still many vaccines that are not being used. and are kept in the vaccine depots of poor countries. UNICEF data also shows that There are currently 681 million doses of the vaccine that are not being used in more than 90 poor countries around the world, according to CARE, a charity that draws numbers from a public database. CARE said so far more than 30 poor countries, including big ones such as the Democratic Republic of the Congo and Nigeria. Less than half of the vaccine was used. COVAX, a global program led by the World Health Organization It has delivered 989 million doses of the COVID-19 vaccine to 144 countries, according to GAVI, the vaccine partner that manages the project. |
  |
|
